SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 375 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | -88.9% | 70 | -87.7% | 0.00% | -87.5% |
| Q1 2022 | $45,000 | -11.8% | 570 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $51,000 | -48.5% | 570 | -46.7% | 0.01% | -55.6% |
| Q3 2021 | $99,000 | +19.3% | 1,070 | 0.0% | 0.02% | +20.0% |
| Q2 2021 | $83,000 | +3.8% | 1,070 | 0.0% | 0.02% | -16.7% |
| Q1 2021 | $80,000 | -18.4% | 1,070 | +85.8% | 0.02% | -28.0% |
| Q4 2020 | $98,000 | +60.7% | 576 | +32.1% | 0.02% | +25.0% |
| Q3 2020 | $61,000 | +60.5% | 436 | +84.7% | 0.02% | +33.3% |
| Q2 2020 | $38,000 | +81.0% | 236 | +11.8% | 0.02% | +50.0% |
| Q1 2020 | $21,000 | +50.0% | 211 | +99.1% | 0.01% | +100.0% |
| Q4 2019 | $14,000 | +75.0% | 106 | 0.0% | 0.01% | +25.0% |
| Q3 2019 | $8,000 | -50.0% | 106 | 0.0% | 0.00% | -42.9% |
| Q2 2019 | $16,000 | +1500.0% | 106 | +1666.7% | 0.01% | +600.0% |
| Q1 2019 | $1,000 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,999,453 | $413,414,607 | 13.31% |
| Casdin Capital, LLC | 1,160,000 | $159,882,800 | 13.17% |
| Ikarian Capital, LLC | 271,300 | $37,393,279 | 8.48% |
| Avoro Capital Advisors LLC | 3,650,000 | $503,079,500 | 7.46% |
| Evolutionary Tree Capital Management, LLC | 36,190 | $4,988,068 | 6.91% |
| Finepoint Capital LP | 122,757 | $16,919,597 | 6.46% |
| Ikarian Capital, LLC | 205,400 | $28,310,282 | 6.42% |
| Boxer Capital, LLC | 775,000 | $106,818 | 5.25% |
| Ghost Tree Capital, LLC | 125,000 | $17,229,000 | 5.09% |
| Logos Global Management LP | 220,000 | $30,322,600 | 4.34% |